Target Group Inc. (CBDY) stock
CBDYOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
$0.00+0.00 (0.00%)
Close on Oct 19, 2026Market cap $431.92KP/E –Yield –
Target operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Target's operating cash flow for the twelve months ending Jun 30, 2026 was -$1.07M, down 433.8% year over year. For fiscal 2025 it was -$842.43K, down 139.0% from the year before. The highest annual figure on record is $2.16M in fiscal 2024.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$842.43K | -139.0% |
| FY2024 | Dec 31, 2024 | $2.16M | – |
| FY2023 | Dec 31, 2023 | -$589.61K | – |
| FY2022 | Dec 31, 2022 | -$1.01M | -1113.6% |
| FY2021 | Dec 31, 2021 | $100.12K | – |
| FY2020 | Dec 31, 2020 | -$1.43M | – |
| FY2019 | Dec 31, 2019 | -$5.52M | – |
| FY2018 | Dec 31, 2018 | -$699.47K | – |
| FY2017 | Dec 31, 2017 | -$262.05K | – |
| FY2016 | Dec 31, 2016 | -$421.00K | – |
| FY2015 | Dec 31, 2015 | -$192.44K | – |
| FY2014 | Dec 31, 2014 | -$37.34K | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$222.91K | -146.0% |
| Q1 FY2026 | Mar 31, 2026 | -$93.67K | – |
| Q4 FY2025 | Dec 31, 2025 | -$250.79K | -134.1% |
| Q3 FY2025 | Sep 30, 2025 | -$506.07K | – |
| Q2 FY2025 | Jun 30, 2025 | $484.43K | -50.6% |
| Q1 FY2025 | Mar 31, 2025 | -$570.01K | -173.6% |
| Q4 FY2024 | Dec 31, 2024 | $736.44K | +154.2% |
| Q3 FY2024 | Sep 30, 2024 | -$329.28K | – |
| Q2 FY2024 | Jun 30, 2024 | $981.08K | +47.8% |
| Q1 FY2024 | Mar 31, 2024 | $774.45K | – |
| Q4 FY2023 | Dec 31, 2023 | $289.67K | +423.1% |
| Q3 FY2023 | Sep 30, 2023 | -$1.36M | -1151.5% |
| Q2 FY2023 | Jun 30, 2023 | $663.69K | – |
| Q1 FY2023 | Mar 31, 2023 | -$186.76K | -226.2% |
| Q4 FY2022 | Dec 31, 2022 | $55.38K | -90.9% |
| Q3 FY2022 | Sep 30, 2022 | $128.98K | – |
| Q2 FY2022 | Jun 30, 2022 | -$1.35M | – |
| Q1 FY2022 | Mar 31, 2022 | $148.04K | +86.3% |
| Q4 FY2021 | Dec 31, 2021 | $607.95K | – |
| Q3 FY2021 | Sep 30, 2021 | -$236.23K | – |
| Q2 FY2021 | Jun 30, 2021 | -$351.06K | – |
| Q1 FY2021 | Mar 31, 2021 | $79.45K | – |
| Q4 FY2020 | Dec 31, 2020 | -$213.37K | – |
| Q3 FY2020 | Sep 30, 2020 | -$285.04K | – |
| Q2 FY2020 | Jun 30, 2020 | -$64.78K | -134.2% |
| Q1 FY2020 | Mar 31, 2020 | -$869.97K | – |
| Q4 FY2019 | Dec 31, 2019 | -$84.23K | – |
| Q3 FY2019 | Sep 30, 2019 | -$2.51M | – |
| Q4 FY2018 | Dec 31, 2018 | $189.24K | – |
| Q3 FY2018 | Sep 30, 2018 | -$778.26K | – |
| Q2 FY2018 | Jun 30, 2018 | -$55.43K | – |
| Q1 FY2018 | Mar 31, 2018 | -$55.01K | – |
| Q2 FY2017 | Jun 30, 2017 | -$72.86K | – |
| Q1 FY2017 | Mar 31, 2017 | -$70.86K | – |
| Q4 FY2016 | Dec 31, 2016 | -$8.00K | – |
| Q3 FY2016 | Sep 30, 2016 | -$158.92K | – |
| Q4 FY2015 | Dec 31, 2015 | -$64.36K | – |
See a number that looks wrong?